Price T Rowe Associates Inc G1 Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 33,732 shares of GTHX stock, worth $241,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,732
Previous 17,755
89.99%
Holding current value
$241,183
Previous $77,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GTHX
# of Institutions
78Shares Held
18.2MCall Options Held
1.85MPut Options Held
1.18M-
Black Rock Inc. New York, NY3.08MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$17.8 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.36MShares$9.74 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.25MShares$8.9 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$7.72 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $306M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...